exo
Rail, Bus & Taxi · Canada · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
255 Laurier Blvd Ste 120, McMasterville,...Phone Number
(514) 287-8726Website
exo.quebecRevenue
$60.9 MillionIndustry
About exo
exo Org Chart
Is exo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on exo recently announced quarterly report
Website visits: Recent activity has been detected on your website
exo, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once exo has new funding data
Check if exo has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when exo launches new products
Check out if exo is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at exo
Click to see if exo had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at exo
Find more new buyers
Compare Similar Companies to exo
Compare insights from companies similar to exo, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
exo is experiencing very low activity levels compared to other companies in the Transportation sector.
What does this means?
exo is drawing exceptional interest within the Transportation industry, suggesting notable developments or strong market momentum, learn more about exo.
exo Tech Stack
A closer look at the technologies used by exo
Most Recent Scoops
exo News & Media
Exo-Top, NurExone’s wholly owned U.S. Subsidiary, Enters Into Binding MOU For Naïve Exosome Distribution in Mexico
TORONTO, Ontario and HAIFA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce today that its wholly owned U.S. subsidiary, Exo-Top Inc. (“Exo-Top”), has entered into a binding memorandum of understanding (the “MOU”) setting out the principal commercial terms for a proposed definitive distribution agreement (the “DeNurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization
TORONTO, Ontario and HAIFA, Israel and POMPANO BEACH, Florida, April 07, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) and BioXtek Inc. (“BioXtek”) today announced that Exo-Top Inc., NurExone’s wholly owned U.S. subsidiary, (“Exo-Top” and together, with BioXtek, the “Parties”) has entered into a non-binding letter of intent (the “LOI”) with BioXtek, a Florida-based company, to explore a strategic partnership in the field of reNurExone Strengthens U.S. Manufacturing Strategy Through Exo-Top Sublicense Agreement
Exo-Top Inc. positioned as a strategic U.S. subsidiary supporting manufacturing, clinical advancement and long-term value creation Exo-Top Inc. positioned as a strategic U.S. subsidiary supporting manufacturing, clinical advancement and long-term value creationEXO's Lay Apologizes for Missing Fan Meeting on the Day: “I'm Sorry Due to an Important ...
EXO’s Chinese member Lay has issued an apology after his sudden absence from a scheduled fan meeting. EXO held their fa
Top Rail, Bus & Taxi Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding exo
Exo operates a public transit service by train and bus, offering transportation for the people traveling in Canada.... Read More